Switzerland
Aescap et al. in €30m Biocartis round
Aescap, alongside other existing backers and new strategic investors Debiopharm Group and Johnson & Johnson, has particpated in a €30m series B funding round for Biocartis SA.
EPS Value Plus AG sells investment in Meyer Burger/3S Industries
Listed New Value has sold its interest in Meyer Burger/3S Industries on the stock market, which led to preliminary profits of approximately CHF 5.5m for the financial year ending 31 March.
DLJ in $165 million investment in Landis+Gyr
DLJ Merchant Banking Partners, part of Credit Suisse’s Asset Management division, has taken part in a $165m investment in Landis+Gyr.
Deutsche unquote" April 2010
The April issue of Deutsche unquote" is now available to download.
Capvis' Orior to list on Swiss exchange
Capvis portfolio company Orior AG is considering a listing on the Swiss stock exchange, and is expected to raise CHF 80m from the IPO.
DBAG to raise €200m expansion capital fund
Deutsche Beteiligungs AG plans to raise a €200m expansion capital fund.
Mountain out of a Molehill
The over-used phrase “cautiously optimistic” sums up expectations for 2010. While some firms celebrated successes in 2009, many more had their heads down with crisis management, refinancing their existing portfolio companies and constantly readjusting...
Deutsche unquote" March 2010
The March issue of Deutsche unquote" is now available to download.
Equita sells PMA to Thomas & Betts
Equita has sold PMA Group, a manufacturer of cable protection systems, to Thomas & Betts for EUR 85m.
CapVis sells Ticketcorner Holding AG
CapVis and the other shareholders have sold ticketing company Ticketcorner to strategic investor CTS EVENTIM AG.
Russia Partners and Bessemer Venture Partners invest in Parallels
Russia Partners, an affiliate of Siguler Guff, and Bessemer Venture Partners have invested in software company Parallels.
EXCLUSIVE - Argos Soditic reaps 4.2x on Kägi sale
Argos Soditic has sold its stake in Kägi to an undisclosed Swiss industrial family, generating 4.2x money.
Argos Soditic reaps 4.2x on Kägi exit
Argos Soditic has sold its stake in Kägi to an undisclosed Swiss industrial family, which acquired the company with all cash and wiped out its debt, for a 4.2x multiple and an IRR of 125 to 130.
Q&A: Secondary chances
Hanspeter Bader, head of private equity at Unigestion, talks with Mareen Goebel about the secondaries space and current issues with fundraising
BioMedPartners strengthens management team
Healthcare venture firm BioMedPartners has strengthened its management with Josef Bissig as new venture partner.
Deutsche unquote" January 2010
The most recent issue of Deutsche unquote" features: an update on the AIFM directive; a GP sentiment survey; high yield feature, in-depth reporting on deals and exits...and much more. Download your PDF here.